Faculty Opinions recommendation of Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
2014 ◽
Vol 7
(4)
◽
pp. 295-305
◽
2019 ◽
Vol 13
(6)
◽
pp. 921-931
◽
2011 ◽
Vol 4
(1)
◽
pp. 71-78
◽